Literature DB >> 23202871

[Bilateral bisphosphonate-associated osteonecrosis of the external ear canal : a rare case].

F Bast1, H Fuss, T Schrom.   

Abstract

Osteonecrosis of the mandible is a well-known and dreaded complication after the administration of bisphosphonates. Only a few cases of bisphosphonate-associated osteonecrosis of the external ear canal have been described. Especially after long-lasting bisphosphonate therapy, for example in patients with multiple myeloma, an ulceration of the floor of the bony external auditory canal should be treated surgically and be distinguished from radioosteonecrosis, malignant external otitis, or carcinoma of the external ear.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23202871     DOI: 10.1007/s00106-012-2554-6

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  9 in total

1.  Bisphosphonate-associated osteonecrosis of the auditory canal.

Authors:  Mark N Polizzotto; Vincent Cousins; Anthony P Schwarer
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

3.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

4.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

5.  Bisphosphonate-induced osteonecrosis of the external ear canal: a retrospective study.

Authors:  K Froelich; A Radeloff; C Köhler; R Mlynski; J Müller; R Hagen; N H Kleinsasser
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-16       Impact factor: 2.503

6.  Benign osteonecrosis of the external ear canal.

Authors:  M Wolf; S Nusem-Horowitz; S T Zwas; A Horowitz; J Kronenberg
Journal:  Laryngoscope       Date:  1997-04       Impact factor: 3.325

7.  Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

Authors:  Robert E Marx
Journal:  J Oral Maxillofac Surg       Date:  2003-09       Impact factor: 1.895

Review 8.  Management of bisphosphonate treatment in clinical practice.

Authors:  Matti S Aapro
Journal:  Semin Oncol       Date:  2007-12       Impact factor: 4.929

Review 9.  A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.

Authors:  Michael Pazianas; Paul Miller; William A Blumentals; Myriam Bernal; Prajesh Kothawala
Journal:  Clin Ther       Date:  2007-08       Impact factor: 3.393

  9 in total
  4 in total

1.  [Diagnostic imaging of drug-induced osteonecrosis of the jaw].

Authors:  V Hingst; M-A Weber
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

Review 2.  External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.

Authors:  A-L Thorsteinsson; P Vestergaard; P Eiken
Journal:  Osteoporos Int       Date:  2014-03-25       Impact factor: 4.507

3.  Histologic evaluation of femoral nerve demyelinating and axonal neuropathy in Wistar rats due to alendronate intake: a randomised study.

Authors:  Papamitsou Theodora; Papakoulas Apostolos; Papaliagkas Vasileios; Karachrysafi Sofia; Dietrich Eva-Maria; Sioga Antonia
Journal:  J Biol Res (Thessalon)       Date:  2020-02-18       Impact factor: 1.889

Review 4.  [Management of medication-related osteonecrosis of the jaw-a review of recent study results in comparison to established strategies].

Authors:  Matthias Tröltzsch; Markus Tröltzsch; Christoph Pautke; Sven Otto
Journal:  HNO       Date:  2022-01-20       Impact factor: 1.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.